Article citationsMore>>

Tsao, C., Darby, I., Ebeling, P.R., Walsh, K., O’Brien-Simpson, N., Reynolds, E., et al. (2013) Oral Health Risk Factors for Bisphosphonate-Associated Jaw Osteonecrosis. Journal of Oral and Maxillofacial Surgery, 71, 1360-1366.
https://doi.org/10.1016/j.joms.2013.02.016

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.